Metabolomics and Its Potential in Drug Discovery and Development From TCM

被引:4
作者
Hang Chu [1 ]
Ai-Hua Zhang [1 ]
Ying Han [1 ]
Xi-Jun Wang [1 ]
机构
[1] National TCM Key Lab of Serum Pharmacochemistry, Key Laboratory of Metabolomics and Chinmedomics, Department of Pharmaceutical Analysis,Heilongjiang University of Chinese Medicine
基金
黑龙江省自然科学基金;
关键词
Metabolomics; traditional Chinese medicine; formulae; biomarker; drug discovery;
D O I
暂无
中图分类号
R28 [中药学];
学科分类号
1008 ;
摘要
Metabolomics, an omic science in systems biology, is the comprehensive profiling of metabolic changes occurring in living systems and has been widely used in the modern research of traditional Chinese medicine(TCM). TCM is a complex medical science, which reflects rich philosophical dialectical thought, puts the human body into a large system for observation and keeps human in a healthy status. For TCM aroused great interest in the whole world, herbs and Chinese medical formulae(CMF) as treatment methods have also been widely attention.Metabolomics represents a powerful way that provides a dynamic drawing of the phenotype of biological systems via the research of endogenous metabolites, and its methods are similar to those of TCM. This review summarizes the advantages of metabolomics, highlight the key role of biomarkers for drug discovery and development of TCM.
引用
收藏
页码:26 / 32
页数:7
相关论文
共 50 条
  • [31] Proteomics in biomarker discovery and drug development
    He, QY
    Chiu, JF
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 89 (05) : 868 - 886
  • [32] VERTEBRATE MELANOPHORES AS POTENTIAL MODEL FOR DRUG DISCOVERY AND DEVELOPMENT: A REVIEW
    Salim, Saima
    Ali, Sharique A.
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2011, 16 (01) : 162 - 200
  • [33] Emerging field of metabolomics: Big promise for cancer biomarker identification and drug discovery
    Patel, Seema
    Ahmed, Shadab
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2015, 107 : 63 - 74
  • [34] Discovery of Potential Biomarkers That Discriminate Early Stage NSCLC from Controls by Non-Targeted Metabolomics Profiling
    Kim, J.
    Balshaw, R.
    Trevena, C.
    Banerji, S.
    Murphy, L.
    Dawe, D.
    Tan, L.
    Srinathan, S.
    Buduhan, G.
    Kidane, B.
    Qing, G.
    Domaratzki, M.
    Aliani, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S795 - S796
  • [35] Metabolomics in alcohol research and drug development
    Harrigan, George G.
    Maguire, Greg
    Boros, Laszlo
    ALCOHOL RESEARCH & HEALTH, 2008, 31 (01) : 26 - 35
  • [36] Drug discovery for DNA break repair system by screening from TCM database and molecular dynamics approach
    Chang, Tung-Ti
    Sun, Mao-Feng
    Chen, Kuan-Chung
    Wong, Yung-Hao
    Yang, Shun-Chieh
    Chen, Hsin-Yi
    Tsai, Fuu-Jen
    Fisher, Mark
    Lee, Chun-Lin
    Fang, Wen-Chang
    Chen, Calvin Yu-Chian
    MOLECULAR SIMULATION, 2011, 37 (09) : 804 - 811
  • [37] Molecular imaging in drug discovery and development: Potential and limitations of nonnuclear methods
    Rudin, Markus
    Rausch, Martin
    Stoeckli, Markus
    MOLECULAR IMAGING AND BIOLOGY, 2005, 7 (01) : 5 - 13
  • [38] The potential of alkaloids in drug discovery
    Cordell, GA
    Quinn-Beattie, ML
    Farnsworth, NR
    PHYTOTHERAPY RESEARCH, 2001, 15 (03) : 183 - 205
  • [39] Molecular Imaging in Drug Discovery and Development: Potential and Limitations of Nonnuclear Methods
    Markus Rudin
    Martin Rausch
    Markus Stoeckli
    Molecular Imaging and Biology, 2005, 7 : 5 - 13
  • [40] Natural Products in Drug Discovery: Approaches and Development
    Tresina, Pious Sons
    Selvam, Murugeswaran Santhiya
    Rajesh, Authinarayanan
    Doss, Asirvatham
    Mohan, Veerabahu Ramasamy
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (35A) : 93 - 110